{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T04:31:09Z","timestamp":1764131469026,"version":"3.41.2"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Reports"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.pharep.2016.12.010","type":"journal-article","created":{"date-parts":[[2016,12,19]],"date-time":"2016-12-19T02:16:24Z","timestamp":1482113784000},"page":"512-519","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Anti-inflammatory and antithrombotic effects of nicotine exposure in oral contraceptive-induced insulin resistance are glucocorticoid-independent"],"prefix":"10.1007","volume":"69","author":[{"given":"Lawrence Aderemi","family":"Olatunji","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olugbenga Samuel","family":"Michael","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oluwaseun Aremu","family":"Adeyanju","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanuel Damilare","family":"Areola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayodele Olufemi","family":"Soladoye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"10.1016\/j.pharep.2016.12.010_bib0005","unstructured":"Centers for Disease Control and Prevention (CDC). National diabetes statistics report 2014. Atlanta, GA: Centers for Disease Control and Prevention"},{"key":"10.1016\/j.pharep.2016.12.010_bib0010","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.cmet.2007.01.002","article-title":"Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated fat-, and obesity-induced insulin resistance","volume":"5","author":"Holland","year":"2007","journal-title":"Cell Metab"},{"key":"10.1016\/j.pharep.2016.12.010_bib0015","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1007\/s00125-010-1684-1","article-title":"Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis: the missing links: the Claude Bernard Lecture 2009","volume":"53","author":"DeFronzo","year":"2010","journal-title":"Diabetologia"},{"key":"10.1016\/j.pharep.2016.12.010_bib0020","first-page":"R233","article-title":"Gender, sex hormones, and vascular tone","volume":"286","author":"Orshall","year":"2004","journal-title":"Am J Physiol"},{"key":"10.1016\/j.pharep.2016.12.010_bib0025","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Writing Group for the Women\u2019s Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women\u2019s Health Initiative randomized controlled trial","volume":"288","author":"Rossouw","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.pharep.2016.12.010_bib0030","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1056\/NEJMoa1111840","article-title":"Thrombotic stroke and myocardial infarction with hormonal contraception","volume":"366","author":"Lidegaard","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharep.2016.12.010_bib0035","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.beem.2012.11.003","article-title":"Hormonal contraceptives and arterial disease: an epidemiological update","volume":"27","author":"Plu-Bureau","year":"2013","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.pharep.2016.12.010_bib0040","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/j.ehj.2004.03.011","article-title":"Atherothrombosis: a widespread disease with unpredictable and life-threatening consequences","volume":"25","author":"Viles-Gonzalez","year":"2004","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pharep.2016.12.010_bib0045","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1161\/ATVBAHA.108.179705","article-title":"Inflammation in atherosclerosis","volume":"232","author":"Libby","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.pharep.2016.12.010_bib0050","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1016\/j.ahj.2004.04.028","article-title":"High-sensitivity C-reactive protein, inflammation, and cardiovascular risk: from concept to clinical practice to clinical benefit","volume":"148","author":"Ridker","year":"2004","journal-title":"Am Heart J"},{"key":"10.1016\/j.pharep.2016.12.010_bib0055","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1046\/j.1365-2141.1999.01158.x","article-title":"Tunstall-pedoe H, Lowe GDO: Associations of blood rheology and interleukin-6 with cardiovascular risk factors and prevalent cardiovascular disease","volume":"104","author":"Woodward","year":"1999","journal-title":"Br J Haematol"},{"key":"10.1016\/j.pharep.2016.12.010_bib0060","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1161\/CIRCULATIONAHA.106.635029","article-title":"Relative value of inflammatory, hemostatic, and rheological factors for incident myocardial infarction and stroke: the Edinburgh Artery Study","volume":"115","author":"Tzoulaki","year":"2007","journal-title":"Circulation"},{"issue":"18","key":"10.1016\/j.pharep.2016.12.010_bib0065","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1001\/jama.279.18.1477","article-title":"Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies","volume":"279","author":"Danesh","year":"1998","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.pharep.2016.12.010_bib0070","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1161\/CIRCOUTCOMES.108.831024","article-title":"Neutrophilia predicts death and heart failure after myocardial infarction: a community-based study","volume":"2","author":"Arruda-Olson","year":"2009","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"3","key":"10.1016\/j.pharep.2016.12.010_bib0075","doi-asserted-by":"crossref","first-page":"s5","DOI":"10.1161\/ATVBAHA.107.158915","article-title":"Platelets: inflammatory firebugs of vascular walls","volume":"28","author":"May","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3","key":"10.1016\/j.pharep.2016.12.010_bib0080","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1177\/1076029613519851","article-title":"The utility of the platelet\u2013lymphocyte ratio for predicting no reflow in patients with ST-segment elevation myocardial infarction","volume":"21","author":"Yildiz","year":"2015","journal-title":"Clin Appl Thromb Hemost"},{"issue":"2","key":"10.1016\/j.pharep.2016.12.010_bib0085","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s11239-014-1103-4","article-title":"Platelet-lymphocyte ratio is an independent predictor for cardiovascular disease in obstructive sleep apnea syndrome","volume":"39","author":"Koseoglu","year":"2015","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.pharep.2016.12.010_bib0090","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1161\/CIRCULATIONAHA.104.521708","article-title":"Role of smoking in global and regional cardiovascular mortality","volume":"112","author":"Ezzati","year":"2005","journal-title":"Circulation"},{"issue":"18","key":"10.1016\/j.pharep.2016.12.010_bib0095","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1056\/NEJM199705013361802","article-title":"Coronary risk factors and plaque morphology in men with coronary disease who died suddenly","volume":"336","author":"Burke","year":"1997","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.pharep.2016.12.010_bib0100","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1161\/CIRCULATIONAHA.109.857888","article-title":"Cardiovascular mortality and exposure to airborne fine particulate matter and cigarette smoke: shape of the exposure-response relationship","volume":"120","author":"Pope","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.pharep.2016.12.010_bib0105","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1046\/j.1365-2796.2002.01014.x","article-title":"Effects of cigarette smoking or nicotine replacement on cardiovascular risk factors and parameters of haemorheology","volume":"252","author":"Haustein","year":"2002","journal-title":"J Intern Med"},{"key":"10.1016\/j.pharep.2016.12.010_bib0110","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1097\/MBC.0b013e328331e6f2","article-title":"Upregulation of platelet CD40, CD40 ligand (CD40L) and P-Selectin expression in cigarette smokers: a flow cytometry study","volume":"20","author":"Neubauer","year":"2009","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.pharep.2016.12.010_bib0115","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00380-010-0036-x","article-title":"Plasma concentrations of soluble CD40 ligand in smokers with acute myocardial infarction: a pilot study","volume":"26","author":"Kayrak","year":"2011","journal-title":"Heart Vessels"},{"key":"10.1016\/j.pharep.2016.12.010_bib0120","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0140-6736(94)90933-4","article-title":"Meta-analysis on efficacy of nicotine replacement therapies in smoking cessation","volume":"343","author":"Silagy","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.pharep.2016.12.010_bib0125","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1124\/jpet.300.3.876","article-title":"Nicotine reduces the incidence of type I diabetes in mice","volume":"300","author":"Mabley","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharep.2016.12.010_bib0130","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1038\/nm1124","article-title":"Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis","volume":"10","author":"Wang","year":"2004","journal-title":"Nat Med"},{"key":"10.1016\/j.pharep.2016.12.010_bib0135","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s000110050597","article-title":"An investigation into the effect and mechanisms of action of nicotine in inflammatory bowel disease","volume":"49","author":"Sykes","year":"2000","journal-title":"Inflamm Res"},{"issue":"5","key":"10.1016\/j.pharep.2016.12.010_bib0140","doi-asserted-by":"crossref","first-page":"e469","DOI":"10.1371\/journal.pone.0000469","article-title":"Nicotine protects kidney from renal ischemia\/reperfusion injury through the cholinergic anti-inflammatory pathway","volume":"2","author":"Sadis","year":"2007","journal-title":"PLoS One"},{"key":"10.1016\/j.pharep.2016.12.010_bib0145","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1161\/01.STR.30.3.651","article-title":"Nicotine increases plasminogen activator inhibitor-1 production by human brain endothelial cells via protein kinase C\u2013Associated pathway","volume":"30","author":"Zidovetzki","year":"1999","journal-title":"Stroke"},{"key":"10.1016\/j.pharep.2016.12.010_bib0150","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1046\/j.1365-2796.2001.00840.x","article-title":"Nicotine infusion acutely impairs insulin sensitivity in type 2 diabetic patients but not in healthy subjects","volume":"249","author":"Axelsson","year":"2001","journal-title":"J Intern Med"},{"issue":"1","key":"10.1016\/j.pharep.2016.12.010_bib0155","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1253\/circj.CJ-10-0335","article-title":"High blood viscosity is closely associated with cigarette smoking and markedly reduced by smoking cessation","volume":"75","author":"Shimada","year":"2011","journal-title":"Circ J"},{"issue":"12","key":"10.1016\/j.pharep.2016.12.010_bib0160","doi-asserted-by":"crossref","first-page":"e51217","DOI":"10.1371\/journal.pone.0051217","article-title":"Chronic exposure to nicotine enhances insulin sensitivity through \u03b17 nicotinic acetylcholine receptor-STA pathway","volume":"7","author":"Xu","year":"2012","journal-title":"PLoS ONE"},{"issue":"4","key":"10.1016\/j.pharep.2016.12.010_bib0165","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/nm.3826","article-title":"Activation of AMPK(2 in adipocytes is essential for nicotine-induced insulin resistance in vivo","volume":"21","author":"Wu","year":"2015","journal-title":"Nat Med"},{"key":"10.1016\/j.pharep.2016.12.010_bib0170","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1056\/NEJMra050541","article-title":"Anti-inflammatory action of glucocorticoids\u2014new mechanisms for old drugs","volume":"353","author":"Rhen","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharep.2016.12.010_bib0175","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1210\/jc.2012-3582","article-title":"Multisystem morbidity and mortality in Cushing\u2019s syndrome: a cohort study","volume":"98","author":"Dekkers","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.pharep.2016.12.010_bib0180","doi-asserted-by":"crossref","first-page":"M11","DOI":"10.1530\/EJE-15-0198","article-title":"Adverse effects of glucocorticoids: coagulopathy","volume":"173","author":"Coelho","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.pharep.2016.12.010_bib0185","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/BF03345709","article-title":"Blood coagulation and fibrinolysis in patients with Cushing\u2019s syndrome: increased plasminogen activator inhibitor-1, decreased tissue factor pathway inhibitor, and unchanged thrombin-activatable fibrinolysis inhibitor levels","volume":"32","author":"Erem","year":"2009","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.pharep.2016.12.010_bib0190","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/j.1365-2265.2012.04479.x","article-title":"Hypercoagulable state in Cushing\u2019s syndrome is reversible following remission","volume":"78","author":"Kastelan","year":"2013","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.pharep.2016.12.010_bib0195","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.2337\/db14-1192","article-title":"Role of plasminogen activator inhibitor-1 in glucocorticoid-induced diabetes and osteopenia in mice","volume":"64","author":"Tamura","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/j.pharep.2016.12.010_bib0200","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1161\/01.ATV.0000242905.41404.68","article-title":"PAI-1 and the metabolic syndrome: links, causes, and consequences","volume":"26","author":"Alessi","year":"2006","journal-title":"Arterioscler Throm Vasc Biol"},{"key":"10.1016\/j.pharep.2016.12.010_bib0205","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0140-6736(87)93050-9","article-title":"Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction","volume":"2","author":"Hamsten","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.pharep.2016.12.010_bib0210","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1160\/TH03-08-0546","article-title":"Plasminogen activator inhibitor-type 1: its plasma determinants and relation with cardiovascular risk","volume":"91","author":"Hoekstra","year":"2004","journal-title":"Thromb Haemost"},{"issue":"2","key":"10.1016\/j.pharep.2016.12.010_bib0215","doi-asserted-by":"crossref","first-page":"336","DOI":"10.2337\/diabetes.53.2.336","article-title":"Prevention of obesity and insulin resistance in mice lacking plasminogen activator inhibitor 1","volume":"53","author":"Ma","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.pharep.2016.12.010_bib0220","first-page":"1","article-title":"Activation of cardiac renin-angiotensin system and plasminogen activator inhibitorgene expressions in oral contraceptive-induced cardiometabolic disorder","author":"Olatunji","year":"2016","journal-title":"Arch Physiol Biochem"},{"key":"10.1016\/j.pharep.2016.12.010_bib0225","first-page":"1","article-title":"Effect of a high-fructose diet on glucose tolerance, plasma lipid and hemorheological parameters during oral contraceptive administration in female rats","volume":"51","author":"Olatunji","year":"2012","journal-title":"Clin Hemorh Micr"},{"key":"10.1016\/j.pharep.2016.12.010_bib0230","first-page":"805","article-title":"Viscosity considerations in the determination of regional circulatory adjustments to anemia","volume":"31","author":"Gordon","year":"1972","journal-title":"Circ Res"},{"issue":"4","key":"10.1016\/j.pharep.2016.12.010_bib0235","doi-asserted-by":"crossref","first-page":"e95079","DOI":"10.1371\/journal.pone.0095079","article-title":"PI3K\/Akt-Independent NOS\/HO activation accounts for the facilitatory effect of nicotine on acetylcholine renal vasodilations: modulation by ovarian hormones","volume":"9","author":"Gohar","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.pharep.2016.12.010_bib0240","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1056\/NEJM199011153232003","article-title":"The effects of different formulations of oral contraceptives agents on lipid and carbohydrate metabolism","volume":"323","author":"Godsland","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharep.2016.12.010_bib0245","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1464-5491.2006.01858.x","article-title":"Metabolic syndrome \u2013 a new world-wide definition. A consensus statement from the International Diabetes Federation","volume":"23","author":"Alberti","year":"2006","journal-title":"Diabetes Med"},{"key":"10.1016\/j.pharep.2016.12.010_bib0250","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/j.jacc.2010.05.034","article-title":"The metabolic syndrome and cardiovascular risk a systemic review and meta-analysis","volume":"56","author":"Mottillo","year":"2010","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.pharep.2016.12.010_bib0255","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1007\/s12975-013-0253-6","article-title":"Oral contraceptives and nicotine synergistically exacerbate cerebral ischemic injury in the female brain","volume":"4","author":"Raval","year":"2013","journal-title":"Transl Stroke Res"},{"key":"10.1016\/j.pharep.2016.12.010_bib0260","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ejphar.2013.03.026","article-title":"Activation of the cholinergic anti-inflammatory pathway by nicotine attenuates hepatic ischemia\/reperfusion injury via heme oxygenase-1induction","volume":"707","author":"Park","year":"2013","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharep.2016.12.010_bib0265","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ejphar.2014.04.019","article-title":"Attenuation of collagen induced arthritis via suppression on Th17 response by activating cholinergic anti-inflammatory pathway with nicotine","volume":"735","author":"Wu","year":"2014","journal-title":"Eur J Pharmacol"}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1734114016304583?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1734114016304583?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T20:36:50Z","timestamp":1752611810000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1016\/j.pharep.2016.12.010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":53,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["S1734114016304583"],"URL":"https:\/\/doi.org\/10.1016\/j.pharep.2016.12.010","relation":{},"ISSN":["1734-1140"],"issn-type":[{"type":"print","value":"1734-1140"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-inflammatory and antithrombotic effects of nicotine exposure in oral contraceptive-induced insulin resistance are glucocorticoid-independent","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharep.2016.12.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Published by Elsevier Sp. z o.o. on behalf of Institute of Pharmacology, Polish Academy of Sciences.","name":"copyright","label":"Copyright"}]}}